Lone Bredo Pedersen

4.7k total citations
34 papers, 1.0k citations indexed

About

Lone Bredo Pedersen is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Lone Bredo Pedersen has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 19 papers in Genetics and 13 papers in Oncology. Recurrent topics in Lone Bredo Pedersen's work include Lymphoma Diagnosis and Treatment (25 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (6 papers). Lone Bredo Pedersen is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (6 papers). Lone Bredo Pedersen collaborates with scholars based in Denmark, Sweden and Finland. Lone Bredo Pedersen's co-authors include Christian H. Geisler, Arne Kolstad, Mats Jerkeman, Carsten Utoft Niemann, Riikka Räty, Kirsten Grønbæk, Jesper Jurlander, Anna Laurell, Christian Winther Eskelund and Niels Smedegaard Andersen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Lone Bredo Pedersen

34 papers receiving 1.0k citations

Peers

Countries citing papers authored by Lone Bredo Pedersen

Since Specialization

Citations

This map shows the geographic impact of Lone Bredo Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lone Bredo Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lone Bredo Pedersen more than expected).

Fields of papers citing papers by Lone Bredo Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lone Bredo Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lone Bredo Pedersen. The network helps show where Lone Bredo Pedersen may publish in the future.

Co-authorship network of co-authors of Lone Bredo Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Lone Bredo Pedersen. A scholar is included among the top collaborators of Lone Bredo Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lone Bredo Pedersen. Lone Bredo Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma 2025 ·Blood Advances ·Leo Meriranta, (unknown), (unknown), Arne Kolstad, Martin Hutchings, Carsten Utoft Niemann, Tarec Christoffer El‐Galaly, Jon Riise, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius, Sirpa Leppä, Mats Jerkeman	1
2	Excellent Clinical Outcomes in Deeply Mutated IGHV Chronic Lymphocytic Leukemia upon Fludarabine and Cyclophosphamide Plus Rituximab 2024 ·Blood ·(unknown), Lone Bredo Pedersen, Thure Mors Haunstrup, (unknown), Rikke Katrine Jentoft Olsen, Michael Møller, (unknown), Caspar da Cunha‐Bang, Carsten Utoft Niemann, Christian Brieghel	1
3	MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial 2023 ·Blood Advances ·Mats Jerkeman, Arne Kolstad, Martin Hutchings, (unknown), Leo Meriranta, Carsten Utoft Niemann, (unknown), Tarec Christoffer El‐Galaly, Jon Riise, Sirpa Leppä, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius	9
4	Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL 2022 ·Leukemia ·Simon Husby, (unknown), Christian Winther Eskelund, Francesco Favero, Jakob S. Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten Utoft Niemann, Joachim Weischenfeldt, Riikka Räty, Thomas Stauffer Larsen, Arne Kolstad, Mats Jerkeman, Kirsten Grønbæk	3
5	Clinical relevance of routine transvaginal ultrasound in women referred with pelvic organ prolapse 2021 ·BMC Women s Health ·Lone Bredo Pedersen, Marianne Glavind‐Kristensen, Pınar Bor	1
6	Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial 2018 ·The Lancet Haematology ·Mats Jerkeman, Christian Winther Eskelund, Martin Hutchings, Riikka Räty, Karin Fahl Wader, Anna Laurell, Helle Toldbod, Lone Bredo Pedersen, Carsten Utoft Niemann, Christina Dahl, Hanne Kuitunen, Christian H. Geisler, Kirsten Grønbæk, Arne Kolstad	100
7	Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment 2018 ·Haematologica ·Christian Brieghel, Savvas Kinalis, Christina W. Yde, Ane Yde Schmidt, Lars Jønson, Michael Asger Andersen, Caspar da Cunha‐Bang, Lone Bredo Pedersen, Christian H. Geisler, Finn Cilius Nielsen, Carsten Utoft Niemann	15
8	TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy 2017 ·Blood ·Christian Winther Eskelund, Christina Dahl, Jakob Werner Hansen, Maj Westman, Arne Kolstad, Lone Bredo Pedersen, Carmen P. Montano‐Almendras, Simon Husby, C. Freiburghaus, Sara Ek, Anja Pedersen, Carsten Utoft Niemann, Riikka Räty, Peter de Nully Brown, Christian H. Geisler, Mette Klarskov Andersen, Per Guldberg, Mats Jerkeman, Kirsten Grønbæk	242
9	Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma 2016 ·Blood ·(unknown), Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, J. Sundberg, Lone Bredo Pedersen, Elisabeth Ralfkiær, Marja-Liisa Karjalainen-Lindsberg, Christer Sundström, Mats Ehinger, Christian H. Geisler, Mats Jerkeman	62
10	Molecular Monitoring and Tailored Strategy with Pre-Emptive Rituximab Treatment for Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-up of 8.5 Years 2016 ·Blood ·Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Christian H. Geisler	4
11	Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia 2014 ·Haematologica ·(unknown), (unknown), Lone Bredo Pedersen, Christian H. Geisler, Κώστας Σταματόπουλος, Richard Rosenquist, Anders Rosén	6
12	Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study 2014 ·Leukemia ·Sarah E. M. Herman, Carsten Utoft Niemann, Mahfooz Farooqui, Jeffrey A. Jones, Rashida Z. Mustafa, Andrew Lipsky, Nakhle S. Saba, Sabrina Martyr, S. Soto, Joseph M. Valdez, (unknown), I. Maric, Katherine R. Calvo, Lone Bredo Pedersen, Geisler Ch, Danping Liu, Gerald E. Marti, Georg Aue, Adrian Wiestner	131
13	Molecular characterization of neoplastic and normal “sister” lymphoblastoid B-cell lines from chronic lymphocytic leukemia 2013 ·Leukemia & lymphoma ·(unknown), Eva Hellqvist, (unknown), Mattias Jansson, Kenneth Nilsson, Per Hultman, Jon Jonasson, Anne Mette Buhl, Lone Bredo Pedersen, Jesper Jurlander, Eva Klein, Nicole Weit, Marco Herling, Richard Rosenquist, Anders Rosén	14
14	Impact of induction chemotherapy regimen on response, safety and outcome in the PRIMA study 2011 ·Ghent University Academic Bibliography (Ghent University) ·Franck Morschhauser, J.F. Seymour, Pierre Feugier, Fritz Offner, Armando López‐Guillermo, (unknown), Lone Bredo Pedersen, Pauline Brice, David Belada, Luc Xerri, Gilles Salles	12
15	Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma 2009 ·Journal of Clinical Oncology ·Niels Smedegaard Andersen, Lone Bredo Pedersen, Anna Laurell, Erkki Elonen, Arne Kolstad, Anne Marie Boesen, Lars Møller Pedersen, Grete F. Lauritzsen, Roald Ekanger, Herman Nilsson‐Ehle, Marie Nordström, (unknown), Mats Jerkeman, Mikael Eriksson, (unknown), Beatrice Malmer, Christian H. Geisler	92
16	CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia 2006 ·European Journal Of Haematology ·Anne Mette Buhl, Jesper Jurlander, Christian H. Geisler, Lone Bredo Pedersen, Mette Klarskov Andersen, Pär Josefsson, Jørgen Holm Petersen, Henrik Leffers	25
17	Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia. 2005 ·Blood ·Pär Josefsson, Jesper Jurlander, Christian H. Geisler, Lone Bredo Pedersen, (unknown), Mette Klarskov Andersen, Henrik Leffers, Anne Mette Buhl	2
18	Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant 2003 ·European Journal Of Haematology ·Niels Smedegaard Andersen, Lone Bredo Pedersen, Erkki Elonen, Anna Johnson, Arne Kolstad, Kaarle Franssila, Ruth Langholm, Elisabeth Ralfkiær, Måns Åkerman, Mikael Eriksson, Outi Kuittinen, Christian H. Geisler, (unknown)	65
19	Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma 2002 ·Experimental Hematology ·Niels Smedegaard Andersen, John W. Donovan, Amy Zuckerman, Lone Bredo Pedersen, Christian H. Geisler, John G. Gribben	23
20	Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells 2000 ·Oncogene ·Pia Klausen, Lone Bredo Pedersen, Jesper Jurlander, Heinz Baumann	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact